Targeting Multiple-Myeloma-Induced Immune Dysfunction to Improve Immunotherapy Outcomes

Multiple myeloma (MM) is a plasma cell malignancy associated with high levels of monoclonal (M) protein in the blood and/or serum. MM can occur de novo or evolve from benign monoclonal gammopathy of undetermined significance (MGUS). Current translational research into MM focuses on the development o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutella, Sergio, Locatelli, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332181/
https://www.ncbi.nlm.nih.gov/pubmed/22567028
http://dx.doi.org/10.1155/2012/196063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332181/
https://www.ncbi.nlm.nih.gov/pubmed/22567028
http://dx.doi.org/10.1155/2012/196063

Ejemplares similares